UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
UBS Group
UBS
|
+$1.56B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$720M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$652M |
| 4 |
Truist Financial
TFC
|
+$553M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$298M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.36B |
| 2 |
Alibaba
BABA
|
+$872M |
| 3 |
AABA
Altaba Inc. Common Stock
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| 1 | Technology | 12.45% |
| 2 | Financials | 9.35% |
| 3 | Healthcare | 8.43% |
| 4 | Consumer Discretionary | 6.92% |
| 5 | Industrials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Ardmore Shipping
ASC
$517M
| $436K | ﹤0.01% |
48,232
+22,756
| +89% | +$206K |
|
4002
Genie Energy
GNE
$397M
| $435K | ﹤0.01% |
56,254
+11,622
| +26% | +$89.9K |
|
|
PFNX
4003
DELISTED
Pfenex Inc.
PFNX
| $435K | ﹤0.01% |
39,575
+16,847
| +74% | +$185K |
|
4004
Transmedics
TMDX
$4.17B
| $434K | ﹤0.01% |
22,844
+11,348
| +99% | +$216K |
|
4005
Arcus Biosciences
RCUS
$1.32B
| $433K | ﹤0.01% |
42,871
+18,040
| +73% | +$182K |
|
|
SRE.PRA
4006
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $433K | ﹤0.01% |
3,610
+946
| +36% | +$113K |
|
4007
Herbalife
HLF
$941M
| $432K | ﹤0.01% |
9,064
+4,777
| +111% | +$228K |
|
4008
IES Holdings
IESC
$7.53B
| $432K | ﹤0.01% |
16,809
+2,506
| +18% | +$64.4K |
|
|
XONE
4009
DELISTED
The ExOne Company
XONE
| $432K | ﹤0.01% |
57,970
-1,810
| -3% | -$13.5K |
|
4010
Medpace
MEDP
$14B
| $431K | ﹤0.01% |
5,124
+577
| +13% | +$48.5K |
|
4011
SI-BONE Inc
SIBN
$630M
| $430K | ﹤0.01% |
19,995
+8,292
| +71% | +$178K |
|
4012
World Acceptance Corp
WRLD
$937M
| $430K | ﹤0.01% |
4,976
+4,351
| +696% | +$376K |
|
4013
Arlo Technologies
ARLO
$1.89B
| $429K | ﹤0.01% |
101,894
+38,264
| +60% | +$161K |
|
4014
Crinetics Pharmaceuticals
CRNX
$3.19B
| $429K | ﹤0.01% |
17,087
+7,888
| +86% | +$198K |
|
|
DDF
4015
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
| $429K | ﹤0.01% |
28,252
+2,137
| +8% | +$32.5K |
|
4016
Kura Oncology
KURA
$716M
| $429K | ﹤0.01% |
31,169
-47,500
| -60% | -$654K |
|
|
RESP
4017
DELISTED
WisdomTree U.S. ESG Fund
RESP
| $429K | ﹤0.01% |
11,619
+2,348
| +25% | +$86.7K |
|
4018
Invesco Dorsey Wright Financial Momentum ETF
PFI
$63.2M
| $427K | ﹤0.01% |
11,036
-651
| -6% | -$25.2K |
|
4019
Phio Pharmaceuticals
PHIO
$11.9M
| $427K | ﹤0.01% |
8
+3
| +60% | +$160K |
|
|
NXG
4020
NXG NextGen Infrastructure Income Fund
NXG
$205M
| $427K | ﹤0.01% |
7,875
+975
| +14% | +$52.9K |
|
|
AGEN
4021
Agenus
AGEN
$140M
| $426K | ﹤0.01% |
5,341
+2,579
| +93% | +$206K |
|
4022
iRobot
IRBT
$134M
| $426K | ﹤0.01% |
8,409
-22
| -0.3% | -$1.12K |
|
4023
REV Group
REVG
$2.88B
| $426K | ﹤0.01% |
34,826
+25,905
| +290% | +$317K |
|
|
MYOK
4024
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $426K | ﹤0.01% |
5,841
+5,656
| +3,057% | +$413K |
|
4025
Allient
ALNT
$790M
| $425K | ﹤0.01% |
13,143
+4,444
| +51% | +$144K |
|